Blood Group Lewis a Antibodies

Santa Cruz Biotechnology offers a broad range of Blood Group Lewis a Antibodies for research applications. Blood Group Lewis a Antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Blood Group Lewis a is a carbohydrate antigen that plays a crucial role in cell-cell interactions and immune responses. It is primarily expressed on the surface of red blood cells and is involved in determining blood group compatibility, making it significant in transfusion medicine and organ transplantation. The Lewis a antigen has been implicated in various pathological conditions, including cancer, where it may influence tumor progression and metastasis. Blood Group Lewis a research continues to reveal new insights into cellular communication and disease mechanisms. Understanding Blood Group Lewis a expression patterns helps advance knowledge in both basic research and clinical applications. Blood Group Lewis a monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance scientific understanding of cellular processes and disease mechanisms.